NICE TO MEET EVOBIOTECH
The company was founded by four members of the major Italian scientific group specialized in the study of extracellular vesicles in the field of regenerative medicine.
Board Member and Chief Operating Officer
Marco Dieci, master's degree in Chemistry.
He brings over 25 years of management experience in the life science industry, specifically in clinical operations management, pharma business development, and market access.
- CEO at Holostem
- Executive Director at the facility of Children Hospital Bambino Gesù in Rome
- CEO of Xellbiogene, and Operations Director at MolMed
EvoBiotech comes from a research team specialized in the field of extracellular vesicles. Prof. Camussi, active in the biomedical research field of stem cells, has been a pioneer on the international landscape of the research on extracellular vesicles. The first discovery goes back to 2007 when Prof. Camussi and Dr. Deregibus demonstrated that extracellular vesicles act as mediators of the exchange of information between cells.
During the following years, the research team of Prof. Camussi deeply studied mechanisms of action of extracellular vesicles and their role in healthy organisms, tumors, and other pathologies. Among the most interesting properties of extracellular vesicles, and specifically of extracellular vesicles released by stem cells, there are regenerative properties. In fact, extracellular vesicles can enter into cells that are damaged by a pathologic condition (such as ischemia or fibrosis), reprogram the behavior of the cell, and activate processes for the restoration of the damage.
Part of the research activity has been dedicated to the study of the techniques of purification and characterization of extracellular vesicles and of their composition and therapeutic potential.
Prof. Camussi has been for a long time an expert member of the International Society for Extracellular Vesicles (ISEV), the firstborn among international societies of experts in the field of extracellular vesicles.